CNTX
NASDAQ
US
Context Therapeutics Inc. - Common Stock
$2.72
▲ +$0.07
(+2.64%)
Vol 1.1M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$135.1M
ROE
-30.9%
D/E
0.00
Beta
1.96
52W
$0–$2
Wall Street Consensus
16 analysts · Apr 20264
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
93.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 40.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.11 | $-0.14 | $-0.03 |
| Sep 2025 | $-0.10 | $-0.10 | $0.00 |
| Jun 2025 | $-0.06 | $-0.09 | $-0.03 |
| Mar 2025 | $-0.06 | $-0.05 | +$0.01 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$17.5M | -$3.3M | -$4.6M | -$8.8M | -$9.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -38.2% | -38.8% | -38.8% | -38.8% | -30.9% | -30.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 19.08 | 19.09 | 19.09 | 19.09 | 13.10 | 13.08 |
Key Ratios
ROA (TTM)
-29.6%
P/B
0.8
EPS (TTM)
$-0.28
CF/Share
$-1.30
52W High
$1.55
52W Low
$0.49
$0.49
52-Week Range
$1.55
Financial Health
Free Cash Flow
-$6.6M
Net Debt
-$76.8M
Cash
$76.9M
Total Debt
$140K
As of Sep 30, 2025
How does CNTX compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
CNTX valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0.8
▼
61%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
CNTX profitability vs Pharmaceuticals peers
ROE
-30.9%
▲
43%
above
peers
(-54.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-29.6%
▲
21%
above
peers
(-37.4%)
vs Peers
vs Industry
Below avg
CNTX financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
13.1
▲
289%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.0
▲
109%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
CNTX fundamentals radar
CNTX
Peer median
Industry
CNTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CNTX vs peers: key metrics
Top Holders
Top 5: 41.86%MPM Bioimpact LLC
11.62%
$27.7M
Blue Owl Capital Holdings LP
8.09%
$19.3M
Deep Track Capital, Lp
8.08%
$19.2M
Nextech Invest, Ltd.
8.08%
$19.2M
Avidity Partners Management…
5.99%
$14.3M
As of Dec 31, 2025
Latest News
No related news yet